AGP Executive Report

Ebola Preparedness & Travel Controls: Kenya’s Health CS Aden Duale said President William Ruto canceled a trip to Congo-Brazzaville after health guidance warned of mandatory 21-day quarantine, with advance staff later quarantined. PBM Scrutiny: Florida AG James Uthmeier issued a civil investigative demand to CVS/Caremark over alleged anticompetitive practices that could squeeze pharmacy choices and raise costs for families. Employer Health Costs: A new report argues fully-insured plans can quietly drain small and mid-size businesses by funding carrier profits rather than care. Mental Health Scale-Up: PsychPlus announced it is acquiring Koa Health to build a larger technology-enabled mental health platform. Hospital Equity Watch: The Lown Hospitals Index found many top hospitals still fall short on health equity, highlighting a gap between social responsibility and clinical rankings. Rural Pharmacy Fragility: Vermont saw multiple independent pharmacy closures tied to wholesaler disputes, underscoring how thin margins threaten access. Sleep Apnea Treatment Update: Holy Name Medical Center began offering Inspire VTM therapy as an alternative for moderate-to-severe obstructive sleep apnea. Health Data Infrastructure (Canada): Canada is investing in the VITAL health data platform to better connect hospital data for research and innovation. Health Services M&A: PwC says deal activity is active but more selective as investors demand reimbursement visibility and margin durability.

AI & Mental Health Safety: A new column digs into how generative AI system prompts steer mental-health chat behavior, raising questions about what guidance may cause the model to help—or mislead. Digital Health Regulation: Conneqt Health filed an FDA Pre-Submission for SphygmoCor Cloud, aiming to move its arterial analytics from dedicated hardware to a cloud SaMD platform. Pharma M&A & Supply: Aurobindo Pharma USA got FTC approval to acquire Lannett for $250M, expanding complex generics and adding U.S. manufacturing capacity. Immunology Deal: AbbVie agreed to buy Apogee Therapeutics for $11B, betting its longer-interval IL-13 antibody (zumilokibart) could improve atopic dermatitis dosing. Public Health & Prevention Economics: A WEF report says low-cost prevention—like hearing aids, home safety, and activity programs—could save nearly $6T by 2040. Health Data Privacy: A Petone pharmacy in New Zealand says patient messages were exposed via its website contact form, then scrubbed from the internet. Workplace/Community Health: Goa flagged off four ambulances for highway medical response, while Liberia’s president received a bill to create a national health insurance fund. Health Risks From Chemicals: Australia approved continued restricted use of paraquat and diquat, with critics warning of Parkinson’s-linked exposure. Market Watch: Indian pharma stocks rallied on reports the U.S. FDA is seeking help from Indian makers to address an ifosfamide injection shortage.

Health Tech & Access: A KFF survey finds 1 in 3 Americans use chatbots for health advice, but experts warn they can sound confident while missing urgent care signals. Clinical Safety Tech: Masimo won FDA clearance for AI-enabled opioid-induced respiratory depression detection in its Radius VSM wearable monitor. Policy & Billing: The No Surprises Act’s new payment dispute rule cuts the dispute initiation fee from $115 to $15, aiming to reduce friction for out-of-network billing fights. Provider Workflow: A new MGMA discussion highlights a 2026 split where physician pay rises even as encounter volume slips, alongside Medicare efficiency adjustments. Digital Health Ops: Frontline Systems launched RASON Desktop to bring simulation and optimization into Power BI for scenario-based decisioning. Public Health & Community: Kansas KDHE awarded Chronic Disease Risk Reduction grants to local groups targeting tobacco, nutrition, and activity. Workforce Health: Chennai relaxed conservancy workers’ hours during a heat wave, adding hydration and rest breaks plus toilet upgrades. Industry Dealmaking: AbbVie agreed to acquire Apogee Therapeutics for about $10.9B, expanding immunology and respiratory pipeline.

Clinical Trials & Pharma R&D: Recce Pharmaceuticals won ethics approval to expand its RECCE® 327 topical gel Phase 3 program for diabetic foot infections, widening eligibility to moderate cases and adding ulcer-level endpoints. Regulation & Accountability: In the Philippines’ Pharmally graft case, a COA officer submitted additional documents tied to alleged anomalies in COVID-19 medical fund transfers. Biotech Partnerships: BioArctic and Eli Lilly struck a deal using BrainTransporter™ tech, with $30M upfront and up to $770M in milestones. Public Health Threats: Ebola in DR Congo has topped 1,000 cases, with health workers falling ill and dying amid weak infection control and PPE shortages. Healthcare Access & Ops: Heallexa says US appointment waits are worsening because patients can’t find open slots, and it’s indexing millions of providers for faster booking. Addiction Safety: UK ketamine use is up sharply, and clinics warn of “ketamine bladder” and lasting damage. Food & Consumer Safety: India’s consumer watchdog fined brands over “100%” health/ingredient claims and ordered withdrawals. Tech for Care: PurpleLab launched an identity resolution tool to connect de-identified patient and HCP data across partners in privacy-preserving setups.

Brain-Computer Interface Breakthrough (China): A Beijing patient with complete spinal cord injury can now walk again after a “Beinao-1” brain-computer interface was implanted alongside spinal cord stimulation and rehab, marking a major step for neurotech-assisted recovery. AI for Health Systems (Europe/Israel): Clalit Health Services is joining PANDAI, a €8M Horizon Europe effort pooling health data across multiple countries to spot and manage future pandemics earlier using AI. Low-Cost Imaging Push (US/Global): Midjourney Medical says its AI whole-body ultrasound scanner can complete a scan in 60 seconds for $2–$3 per session, aiming to expand preventive screening access. Climate-Health Funding (Global): Grand Challenges Canada and partners launched Nexa to back locally led climate and health innovations, targeting $50M+ in investment with a first funding call starting June 22. Drug Pricing Trade Tension (US/Germany): The US opened a trade probe into Germany’s pharmaceutical pricing, arguing “underpayment” for innovative drugs could restrict US commerce and R&D investment. Regulatory/Compliance Pressure (Bangladesh): Beximco Pharma shares jumped amid reports of a possible London delisting reversal, tied to ongoing board and disclosure disputes. Public Health & Access (Canada/UK): Ontario’s health coalition is urging action over LifeLabs/Quest moving lab work out of province, raising concerns about service cuts and turnaround times. Wellness in Schools (India): A girls’ school in Bhiwandi held International Yoga Day sessions to support students’ stress resilience and mindfulness.

Nutrition Crisis: The Philippines’ latest nutrition survey flags stunting rising to 25.3% among children under 5, reversing a decade of progress and raising alarms for learning and long-term health. Disability Inclusion: A Nagaland advocate says disability is still treated as charity instead of a rights issue, with policy gaps and inaccessible environments keeping people excluded. Fraud & Digital Health: Malaysia’s MOH is studying a more secure e-MC system after forged medical certificate cases using doctors’ identities. Mental Health & Family Wellness: Experts warn that long-running unresolved conflict can steadily erode mental health and strain family wellbeing. Healthcare Access & Affordability: In Boston, insurers face scrutiny over proposed 12.9% premium hikes tied to drug and reimbursement costs, while airport and security workers push for affordable coverage. Public Health Policy: India bans 16 fixed-dose drug combinations for lacking therapeutic justification. Connected Care Tech: India’s Dr Trust 360 tops 2.4M users and adds AI analytics for body-composition insights. Industry & Procurement: Medical device firms in Indonesia call for better procurement governance and quality-first purchasing. Health Tech Research: Yale researchers report a brain-computer interface that learns faster when it follows natural brain activity routes.

Digital Health Security: Malaysia’s Health Ministry is studying a more secure digital medical certificate (e-MC) after a case tied to forged sick leave certificates and stolen clinician registration numbers, with five suspects remanded. Drug Safety Crackdown: India’s health ministry has banned 16 fixed-dose combination drugs for lacking therapeutic justification and raising safety concerns, following a Supreme Court-mandated review. Pharma Compliance: Bangladesh authorities raided a Cumilla factory (Modern Drug) for manufacturing at least 22 medicines without licences for them and without an approved technician, seizing unapproved products and equipment. Regulatory Cooperation: Egypt’s Drug Authority signed an MoU with Sierra Leone’s pharmacy board to boost pharmaceutical regulation, technical training, and oversight capacity. Industry Deals: Sun Pharma announced it will acquire Innovcare Lifesciences for $28.7M/₹271.2 crore to expand its global healthcare business. Public Health & Tech: Ghana’s AI strategy aims to curate 1 trillion tokens of local data by 2030, but officials warn the plan depends on cleaner business records—especially for health datasets.

Ebola Response: WHO says 75 healthcare workers have been infected with Ebola in the DRC and Uganda, with 17 deaths, as clinics struggle with limited protective capacity and many patients delay care. Health Diplomacy: Türkiye and Syria signed an MoU to boost cooperation across public health, infectious disease control, maternal/infant health, and areas like vaccines, medical devices, and health information systems. Public Health Access & Policy: Scholars warn Medicaid work requirements could reduce coverage and harm access, even as states are pushed to verify compliance and enforce the rules. Heat Preparedness: Philadelphia declared a Heat Health Emergency for vulnerable groups as heat advisories expand, activating targeted outreach for people at highest risk. TB Push: India reports nearly 23% lower TB incidence over a decade and urges states to intensify its “100-day” TB campaign to find missed cases. Oral Health & Longevity: Hawaii Dental Service’s foundation highlights grants and prevention efforts, stressing that routine dental care can catch whole-body health issues early. Healthcare Business & Tech: UnitedHealth is betting $3B on AI to cut costs and respond to industry backlash, while WHO and other coverage keep spotlighting frontline capacity gaps.

FDA & Vaccines: Merck’s Capvaxive (pneumococcal 21-valent conjugate) gained an FDA-expanded indication for at-risk children and adolescents ages 2–17, backed by the STRIDE-13 phase 3 trial. Behavioral Health Policy: San Bernardino County’s board approved a “landmark” Behavioral Health Services Act roadmap, with about $2.35B projected spending (including ~$915.7M BHSA funding) through 2029. Independent Practice Pressure: Advocates warn health care consolidation is squeezing independent physicians, raising bills and cutting patient choice, while pushing a federal bill to narrow reimbursement gaps. Obesity Care Shift: Boehringer Ingelheim’s Brian Hilberdink argues obesity “success” should mean broader metabolic health, not just weight loss, and highlights access/adherence barriers. Pharma & Capital Markets: Kardigan priced a $400M cardiovascular IPO, while cAMPfield launched a $180M Series A for an oral IBD therapy. PBM Scrutiny & AI: New coverage breaks down PBM audits and how AI may reshape pharmacy benefit management operations. Public Health & Data Security: A class-action settlement finalized over a 2021 health district data breach will pay $1.3M to claimants. Men’s Health & Safety: HHS is seeking testosterone therapy label updates based on newer safety data. Connected-Device Security: GOP senators urged the FCC to review banning Chinese-made health wearables over potential data access risks.

Renal Safety Update: A new study tracking gadolinium-based contrast use in acute kidney injury and dialysis patients found no cases of nephrogenic systemic fibrosis, supporting more permissive GBCA protocols. Research & Industry: University of Galway will lead Ireland’s €64.5m medical devices research centre, backed by a wider national Rinn network with heavy industry participation. Cancer Care Expansion: Mercy Health’s Lourdes Hospital in Paducah is adding radiation oncology, including new equipment, to bring more advanced treatment “under one roof.” Oncology Workforce Training: Merck Foundation and Tata Memorial Centre expanded oncology scholarships across 27 African countries, aiming to close specialist gaps. Digital Health Privacy: The UK ICO opened an inquiry into camera-based monitoring in mental health patients’ bedrooms, raising fresh data protection concerns. Men’s Health Push: Australia’s Men’s Health Week event offers free checks and aims to get more men talking about prevention. AI in Imaging: China’s national medical imaging AI competition is touring Southeast Asia, with a Vietnam event outlining tracks and dataset access ahead of the 2026 contest.

FDA & Vaccines: An FDA advisory panel backed Moderna’s first-of-its-kind mRNA flu vaccine for older adults, moving it toward approval decisions by early August. Food Safety: Los Angeles County and Pasadena warned parents to stop using Nara Organics Whole Milk Organic Infant Formula after a botulism-linked recall tied to suspected cases in multiple states. Urology Innovation: FDA approved a feasibility study of NanoKnife irreversible electroporation (IRE) for benign prostatic hyperplasia, with a multi-site RELIEF trial planned. Healthcare Expansion: Kaiser Permanente opened a new $36M Fischer Crossings Medical Center in Georgia, adding primary, specialty, imaging, lab, and pharmacy services. Medicaid Enforcement: DOJ sued New York over alleged fraud in its Medicaid homecare program, targeting CDPAP management and a vendor. Insurance & Costs: PwC projects medical cost trends near double digits, citing AI-enabled revenue tools, disputes under the No Surprises Act, and GLP-1 popularity. Tech in Health: Google rolled out a major Google Health app update with 13+ changes across tracking, sleep, nutrition, and third-party logs. Global Health Policy: Canada announced $3.3M for Indigenous-led projects to prepare for climate-sensitive infectious diseases. Public Health Infrastructure: Ogun State commissioned a pharma-grade warehouse to improve HIV medicine distribution, supporting free ART for 30,000+ residents. AI & Sovereignty: Cohere’s CEO warned Europe risks “total technological irrelevance” without sovereign AI capabilities.

NHS Drug Shortages: Britain’s pharmacists and GPs warn of “worst on record” medicine shortages, including HRT and key cancer and digestive drugs, forcing some patients to ration or skip meals. Behavioral Health Tech: A new push for tech-supported behavioral therapy aims to move care beyond weekly visits, using between-session tools to support measurement-based progress. Post-Acute EMR Integration: IO Health rolled out an EMR-native overlay for home health and hospice, promising compliance and workflow intelligence without major IT overhauls. Insurer Policy Shifts: Health and life insurers are being exempted from mandatory climate reporting rules, a move framed as cutting compliance costs. Local Mental Health Planning: California’s Sierra County approved a three-year behavioral health plan ahead of the state’s new Behavioral Health Services Act start. Community Pharmacy Expansion: Kenya’s Equity Group launched its first standalone community pharmacy in Nairobi, adding blood sugar and blood pressure screening to expand access. Public Health Preparedness: Bulawayo plans a Public Health Emergency Operations Centre to speed outbreak detection and response. Regulatory/Market Watch: India banned OTC syrup sales, threatening a major cough-and-cold liquid market; meanwhile, Europe braces for heatwaves with practical safety guidance.

NHS Tech Governance: UK MPs pressed the health minister on whether NHS England will use a break clause to replace Palantir as supplier for its federated patient-data platform, with contract scrutiny tied to suitability concerns. AI, Health, and Mental Care: A new APA survey finds most psychologists have already seen patients bring AI into therapy, from self-diagnosis to companionship—raising new questions for clinicians. Behavioral Health Funding: HHS announced $96M for the STREETS behavioral health program plus $612M for additional initiatives aimed at addiction, serious mental illness, and homelessness. Drug-Price Pressure: Massachusetts insurers face hearings over proposed double-digit premium hikes blamed on specialty drug costs and hard-to-negotiate reimbursement rates. PBM Shake-Up: Abarca Health and LucyRx agreed to merge into a larger independent PBM serving 9M+ members, positioning against the biggest PBMs. Healthcare Workforce & Access: South Dakota’s Fall River Health Services is investing in employee housing to ease staffing shortages. Global Health Systems: Togo is set to benefit from a $14.26M West African health program focused on emergency preparedness, regulation, and cross-border “One Health” lab capacity. Medical Innovation: Jazz Pharmaceuticals and AbCellera launched a T-cell engaging multispecific antibody collaboration targeting GI cancers and other solid tumors.

Regulatory & Quality: Apex Health (Qatar) earns “Holistic Role Model” status from the Arab Hospitals Federation, landing 4 Platinum and 12 Gold awards across its network. Insurance Policy Fight: South Korea’s plan to expand health coverage for hair loss is drawing sharp debate over fairness versus strained insurer finances, with a July 4 citizen forum set. AI in Care: Czech firm MAIA Labs secures CE certification for ColoMAIA II, an AI colonoscopy assistant, after a 600-patient trial showing a 61% relative adenoma detection lift. Drug Pricing Pressure: Big pharma is using a UK-style playbook to push back on European drug price moves, with Germany facing threats tied to investment and launches. Mental Health & Treatment Pipeline: The FDA puts psilocybin and an MDMA-like therapy on an accelerated approval track via National Priority Vouchers, signaling faster review for treatment-resistant depression and PTSD. Public Health Alerts: Los Angeles County warns parents to stop using recalled Nara Organics infant formula tied to an infant botulism outbreak. Infection Safety: Memorial Hermann shares findings on improving frontline device cleaning and disinfection adherence through standardized training.

Road Safety Meets Public Health (Venezuela): The National Assembly is considering adding health professionals to a plan to regulate motorcycling, with psychologists, psychiatrists, surgeons and hospital directors helping shape road-safety measures and helmet compliance. Substance Use Burden (Canada): A new report finds about 300,000 hospitalizations in 2024 tied to alcohol or drugs, with most cases driven by broader health effects—not just substance use disorders. Adolescent PCOS Diagnosis (Clinical Guidance): Experts urge caution: PCOS in teens should be diagnosed only when persistent menstrual irregularity and hyperandrogenism are both present, with other conditions ruled out first. Mental Health Diversion (Courts): A court ruling says relapse after residential treatment can be considered when deciding diversion for defendants seeking mental-health-based alternatives to criminal sanctions. Insurance Premium Pressure (Rhode Island): Rhode Island insurers are seeking steep double-digit hikes after a major premium increase last year, as costs and risk shift with GLP-1 use and exchange participation changes. Medicare Drug Pricing (Policy): CMS proposes making Medicare’s drug price negotiation program permanent, aiming for a more predictable framework for manufacturers and patients. Mental Health Care Capacity (Florida): Miami-Dade commissioners unanimously backed a new mental health center pilot to reduce jail and arrest cycles for people with severe untreated illness. Hospital Expansion Plans (North Carolina): Novant and UNC Health filed proposals for major new bed capacity in New Hanover County, with decisions tied to the state’s Certificate of Need process. AI in Sleep and Dementia (Research): New findings link prenatal sleep expectations to postpartum sleep quality, and highlight sleep impairment as a modifiable driver of dementia risk. Lung Health Screening for Veterans (Biotech): bioAffinity Technologies is hosting a webinar on improving lung health screening and early detection strategies for veterans, including those affected by toxic exposures. Pharma Manufacturing Investment (South Carolina): AmbioPharm plans a nearly $120M expansion in Aiken County to scale peptide manufacturing tied to rising demand for GLP-1 and diabetes therapies. Healthcare Tech & Workflow (JMIR): JMIR explores AI clinical decision-making and digital fatigue among health workers, underscoring the human strain behind new tools.

Aesthetics Regulation Push: Define Clinic is calling for tighter UK rules for injectables and laser treatments, citing patient harm from unqualified “high street” providers and urging mandatory medical qualifications, stronger clinical oversight, and proper complication management. Cancer Drug IP: Godavari Biorefineries’ shares drew attention after Japan granted a patent for a cancer-treatment compound, potentially strengthening its global IP pipeline. IVF Safety Questions: A Gurugram couple’s alleged IVF mix-up has reignited debate over how embryos are tracked and protected in fertility labs, with clinics pointing to layered identification and monitoring safeguards. Public Health & Safety: India’s NHRC opened scrutiny after an 8-year-old girl died following a stray dog attack in Punjab, asking the state for a detailed report. College Sports Legal Fight: The NCAA asked a Texas appeals court to pause an injunction that would let Texas Tech QB Brendan Sorsby play this fall despite a gambling ineligibility ruling. Mental Health Spotlight: Australia’s men’s mental health messaging urged people to ask “How are you really going?” to break stigma and encourage early support. Substance Use Monitoring: New research suggests urine drug testing can flag regional shifts in fentanyl exposure that may help explain changes in overdose risk. Wellness in Practice: A study on mindful martial arts highlights flexibility, stress reduction, mental clarity, and better balance.